+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunological reconstitution after autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia. Comparison with an historical non-Hodgkin's lymphoma group



Immunological reconstitution after autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia. Comparison with an historical non-Hodgkin's lymphoma group



Haematologica 89(1): 120-122



The kinetics of immune reconstitution after autologous peripheral blood stem cell transplantation (APBSCT) was examined in a group of 6 patients with chronic lymphocytic leukemia (CLL) and compared to that in an historical group of 12 patients with non-Hodgkin's lymphoma (NHL). Lymphocyte analysis included total lymphocyte count, CD3, CD4, CD8, CD4/8 ratio, CD19, and CD16/56 counts before, on day +15, +30, +60, +90, and +120 and 1 year after transplantation. Immunological recovery in the CLL group was similar to that in the NHL group.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012181047

Download citation: RISBibTeXText

PMID: 14754622


Related references

Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma. British Journal of Haematology 108(2): 415-423, 2000

Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 30(18): 2211-2217, 2012

Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients). Human Gene Therapy 4(6): 821-834, 1993

Low dose recombinent interleukin 2 following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia , mantle cell , and follicular lymphoma. Blood 96(11 Part 2): 350b, 2000

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Journal of Clinical Oncology 12(10): 2176-2186, 1994

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 15(2): 509-517, 1997

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: A prospective randomised trial. European Journal of Cancer 37(14): 1781-1789, 2001

Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 113(23): 6011-6014, 2009

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. Journal of Clinical Oncology 29(10): 1342-1348, 2011

Increased peripheral blood normal myeloid progenitor cells (CFU-GM) in chronic lymphocytic leukemia: A perspective for autologous peripheral blood stem cell transplantation. European Journal of Haematology 54(4): 235-240, 1995

Increased peripheral blood normal myeloid progenitor cells in chronic lymphocytic leukemia A perspective for autologous peripheral blood stem cell transplantation. British Journal of Haematology 87(Suppl. 1): 47, 1994

Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Japanese Journal of Clinical Hematology 43(6): 482-487, 2002